He has played a leading role in the conception and development of Prospective Care, a novel approach to personalized health and an evolving model of national health care delivery. Dr. Snyderman is called upon by Congress, the Institute of Medicine, the National Institutes of Health, and national policy makers to contribute to the debate on health care reform. He plays a prominent role in the leadership of national organizations such as the Association of American Physicians over which he presided in 2003-2004, the Institute of Medicine, of which he was a counselor, and the Association of American Medical Colleges (AAMC) which he chaired in 2001-2002. He is a member of the Institute of Medicine and the American Academy of Arts & Sciences.

Prior to founding Burrill & Company in 1994, Mr. Burrill spent 28 years with Ernst & Young, directing and coordinating the firm's services to clients in the industries of biotechnology, life sciences, high technology, and manufacturing worldwide. Mr. Burrill is a founder of the Foundation for the National Medals of Science and Technology and currently serves on its Board of Directors. He also serves on the Boards of Directors for the Bay Area Science Infrastructure Consortium, BayBio, California Healthcare Institute, Exploratorium, Kellogg Center for Biotechnology, and University of California - San Francisco Foundation.

He serves on the Boards of Agilent Technologies, Pacific Gas and Electric Corporation, Raffles Medical Group of Singapore, McKesson Corporation, and the RAND Health Advisory Board, among others. He also serves in advisory roles to the biotechnology industry. Prior to joining Kaiser Permanente, Dr. Lawrence worked in academic medicine, public health, and international health. He is board certified in general preventive medicine, attended the Advanced Management Program at Harvard, and is a member of the Alpha Omega Alpha Society and the Institute of Medicine.

Under Owen’s leadership, McKesson has pursued a strategy based on focused business unit goals complemented by initiatives that cut across the company. He has played key roles in defining the company’s payor strategy, leading the company’s efforts in electronic prescribing, and expanding its international presence. On the merger and acquisition front he has led the company’s acquisitions of ALI Technologies (medical imaging), Moore Medical (medical supplies), SI/Baker (pharmacy automation), and Sky Pharmaceuticals (packaging). In total he has overseen about 20 acquisitions over the last four years.

Owen joined McKesson in 2001 as Senior Vice President of Corporate Strategy and Business Development. Prior to joining McKesson he was CEO of MindCrossing. He spent 12 years at McKinsey and Company and was elected a Senior Partner (Director) in 1998. During his time at McKinsey he served clients in the pharmaceutical and technology industries. He was a founding partner of McKinsey’s office in Palo Alto and led the Western U.S. for McKinsey’s Business Technology Office. He was recognized by Consulting Magazine as one of the top consultants in the area of business and technology.

Owen grew up in Wales and was educated at Oxford University. He was the youngest law faculty member at Cambridge University and subsequently obtained his MBA from Stanford in 1987. He currently lives in Silicon Valley and is married with two teenage daughters.

He has also served as a member of special review committees for the Institute of Medicine, National Research Council and for the National Science Foundation.  Currently Dr. Prendergast is a member of the Board of Directors of Eli Lilly and the Infectious Disease Research Institute.

Dr. Prendergast obtained his medical degree with honors from the University of the West Indies in 1968.  After internship, he attended Oxford University in England as a Rhodes Scholar where he obtained his bachelors and masters degree in Physiology.  Thereafter, he was a resident in Internal Medicine at Mayo Clinic and then obtained a PhD degree in Biochemistry from the University of Minnesota in 1977.  He joined the Mayo staff as a consultant and assistant professor in the Department of Pharmacology in 1978.  Over the years he rose through the academic ranks at Mayo Clinic to become Professor of Pharmacology and of Biochemistry and Molecular Biology in 1986.  He became the Edmond and Marion Guggenheim Professor in these same subjects in 1988. His principal areas of research have long been protein chemistry and biophysics.  He has published in excess of 300 abstracts and papers.  Currently, in addition to continuing research in protein biophysics, he is building research programs in drug design and discovery and computational biology.

Administratively, Dr. Prendergast has held many responsibilities within Mayo Clinic.  Foremost among these are his appointments as Chair of the Department of Biochemistry and Molecular Biology, 1986-1989 inclusive; Director for Research Mayo Clinic Rochester, 1989-1992 inclusive; Mayo Clinic Rochester Board of Governors, 1989-1996 inclusive; Board of Directors, St. Marys Hospital and Methodist Hospital Rochester and Mayo Foundation Executive Committee (now called Mayo Clinic Board of Governors) 1999-2006 inclusive.  He has served continuously as a member of the Mayo Board of Trustees from 1990-present.  From 1994-2006 inclusive he was the Director of the Mayo Clinic Cancer Center.  In November 2006 he assumed the responsibility as Director for the newly created Mayo Clinic Center for Individualized Medicine, the post he holds today.

Dr. Langheier was awarded the Harvard Reynolds Foundation Fellow for Social Entrepreneurship, which supported his MPH in quantitative methods at the Harvard School of Public Health. He was also a Doris Duke Clinical Research Fellow at the University of California, San Francisco.  He previously served as an alternate representative in the American Medical Association's House of Delegates and as a member of the Association of American Medical Colleges’ Executive Council.

Dr. Langheier received his MD from Duke University School of Medicine, and a Bachelor of Arts degree with honors from Williams College and Cambridge University, in biology and neuroscience.  He currently leads Fitness Forward, a non-profit facilitating healthy lifestyles among youth, and lives in San Francisco with his fiancée, Louise Davis.